Back to search

National and Kapodistrian University of Athens

Ο ορθοκολικός καρκίνος και η διαφοροποίηση της έκφρασης των δεικτών μοριακής βιολογίας και κυτταροκινητικής συμπεριφοράς στις διάφορες μοίρες του παχέος εντέρου

Abstract

dc:description

Cancer of the colon and rectum has been classically viewed as the same disease entity. However it has been well known, for quite a long time, that there are some differences both in the clinical features and gross macroscopic pathology between right and left sited colonic malignancies. Furthermore the distinct embryologic origin between proximal and distal colon, which is reflected in the dual blood supply of the normal colon, has added to the notion that the two segments of the large intestine are literally two different organs, and that two types of carcinogenesis are involved in the development of colorectal neoplasia. The molecular basis of tumor development in the large intestine on the other hand has been extensively studied during the latest years in an effort of better understanding the nature of the disease. Yet, despite intense investigation results reported to date have been inconsistent, and consequently the role of molecular markers in improving information related to the molecular pathogenesis of the disease, has still to be clarified. In the present retrospective, randomized trial, six common molecular markers, p53, PCNA, Ki-67, bcl-2, and Bax, have been immunohistologically determined in a series of 109 colorectal cancer cases. There were 43 right side tumors and 66 left side tumors. Two patients with synchronous lesions in the right and the left colon were included independently in the corresponding patient group, along with the rest of the patients. The ploidy status of the tumor cells was also determined in 93 cases using the image analysis technology which permits more accurate results. The results proved to be inconclusive. No statistically significant differences were detected between right and left sited colonic malignancies concerning all the parameters studied, save the Bax gene expression. Mutational inactivation of the pro-apoptotic Bax gene was detected in a significantly higher incidence in the right colon carcinomas for grade II lesions compared to those of the left colon (p=0.015). Moreover with respect to stage II lesions the aforementioned gene was found to be inactivated much more often in right colon cancers (p=0,085). Actually, right colon adenocarcinomas of moderate differentiation had 4.5 higher probability to express immunohistochemically inactivated Bax gene compared to left colon tumors. The corresponding figure for stage II lesions of the right colon was 4.3. Finally, when multiple logistic regression model was applied the only variable among age, gender, stage, grade, and location which was found to affect the expression of the Bax gene, was the location of the tumor. In particular patients who suffer from right colon carcinomas presented with 2.45 higher probability to express Bax gene inactivation compared to those suffering from left colon lesions. This study however, failed to establish any clinically sound differences with respect to grade differentiation and stage classification between right and left sited malignancies of the large intestine. Staging using the TNM system, and to a lesser extent histologic features currently represent the only practical ways by which clinicians estimate prognosis and therefore mutational inactivation of the pro-apoptotic Bax gene does not seem to correlate to worse prognosis. There are several potential explanations for the failure to establish a role for the molecular markers studied such as the subjective and semi-quantitative nature of immunohistochemical analysis, but an important consideration should be the possibility that specific molecular markers are relevant to only a portion of patients with colorectal cancer. It now seems that approximately 85 percent of colorectal tumors follow the molecular pathway characterized by generalized chromosomal instability. The major “players” include APC, K-ras, 18q genes (such as DCC) and p53 gene. Colorectal cancers with microsatellite instability (the other 15 percent) tend not to develop mutations in the same regulatory genes as cancers with generalized chromosomal instability and may represent a clinically discreet subtype with different biologic behavior. It is therefore probable that molecular markers need to stratify for microsatellite instability status to avoid “contaminating” analyses by including tumors with biologically improved survival. Conclusively, the data presented by this study do not support the hypothesis that there are important biologic differences between the proximal and distal large intestine that might impart different behavior at adenocarcinomas at these sites.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Oikonomakis, Ioannis
  • Οικονομάκης, Ιωάννης

Subjects

dc:subject × 26

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21212

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Oikonomakis, Ioannis; Οικονομάκης, Ιωάννης. Ο ορθοκολικός καρκίνος και η διαφοροποίηση της έκφρασης των δεικτών μοριακής βιολογίας και κυτταροκινητικής συμπεριφοράς στις διάφορες μοίρες του παχέος εντέρου. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/21212